{"id":737,"date":"2003-01-01T12:00:00","date_gmt":"2003-01-01T11:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-arzneimittel"},"modified":"2022-03-17T14:10:17","modified_gmt":"2022-03-17T13:10:17","slug":"neue-arzneimittel","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-arzneimittel","title":{"rendered":"Neue Arzneimittel"},"content":{"rendered":"<p>Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1890,1897,1898,1894,389,255,1895,1888,428,1859,1896,1893,1887,1355,1360,1901,1899,919,1900,1886,1902,1032,1891,1040,1889,1231,1892,1340,1341,1903,1906,834,1619,1911,1708,924,968,1904,1910,257,1502,1909,1499,1907,1498,1876,1905,157,1709,1038,1332,795,794,793,786,792,1908,115,114,905,1881,1100,1099,1867,1845,1883,1882,939,1597,1885,1884,803,802,1098,1097,1350],"class_list":["post-737","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-agalsidase-alfa","tag-agalsidase-beta","tag-alemtuxumab","tag-almotriptan","tag-aromatasehemmer","tag-arzneimittel","tag-botulinumtoxin-typ-b","tag-brinzolamid","tag-capecitabin","tag-celecoxib","tag-choriongonadotropin-alfa","tag-clostridium-botulinum-toxin-typ-b","tag-co-artemether","tag-cox-2-hemmer","tag-coxibe","tag-darbepoetin-alfa","tag-deferipron","tag-desloratadin","tag-dexibuprofen","tag-drospirenon-oestrogen","tag-eiseniii-hydroxid-dextrankomplex","tag-esomeprazol","tag-etanercept","tag-exemestan","tag-ferucarbotran","tag-galantamin","tag-gatifloxacin","tag-glatirameracetat","tag-glatiramerazetat","tag-her2","tag-human-epidermal-growth-factor-receptor-2","tag-imatinib","tag-insulin-glargin","tag-lercanidipin","tag-levetiracetam","tag-levocetirizin","tag-linezolid","tag-lopinavir","tag-lutropin-alfa","tag-medikamente","tag-meningokokken","tag-meningokokken-impfung","tag-meningokokken-meningitis","tag-meningokokkenimpfung","tag-meningokokkenmeningitis","tag-nateglinid","tag-no","tag-orale-antidiabetika","tag-oxcarbazepin","tag-peginterferon-alfa-2b","tag-pioglitazon","tag-pneumokokken","tag-pneumokokken-impfstoff","tag-pneumokokken-impfung","tag-pneumokokkenimpfstoff","tag-pneumokokkenimpfung","tag-proetin-c","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-quetiapin","tag-rasburicase","tag-risedronat","tag-risedronsaeure","tag-rosiglitazon","tag-sirolimus","tag-stickoxid","tag-stickstoffmonoxid","tag-telithromycin","tag-tenecteplase","tag-thyrotropin-alfa","tag-trastuzumab","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-zoledronat","tag-zoledronsaeure","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=737"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/737\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}